Results of docetaxel plus oxaliplatin (DOCOX) ± cetuximab in patients with metastatic gastric and/or gastroesophageal junction adenocarcinoma: Results of a randomised Phase 2 study
- 浏览3
European journal of cancer
2823-2831页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



